Author Guidelines

Submission

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/JMR. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected]..

Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Preprint policy

This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of a manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

For help with submissions, please contact: [email protected]

Aims & Scope

Journal of Molecular Recognition (JMR) publishes original research papers and reviews describing substantial advances in our understanding of molecular recognition phenomena in life sciences, covering all aspects from biochemistry, molecular biology, medicine, and biophysics.  The research may employ experimental, theoretical and/or computational approaches.

Keywords: Molecular recognition, biomolecules, molecular design, biosensors, microcalorimetry, kinetics, protein, nucleic acids, RNA, DNA, amino acid, bio-organic, biophysical, crystallography, cryo-electron microscopy, nuclear magnetic resonance, molecular modeling, molecular simulation, molecular imprinting.

Readership: Biochemists, Biophysicists, Biologists and Medicinal Chemists working in Industry and Academia interested in molecular recognition phenomena in the life sciences.

Journal of Molecular Recognition publishes the best research presented at the AFM BioMed Conferences. For more information about this partnership, see here.

Manuscript Categories & Requirements

i. Research Articles
Page limit: Between 15 and 20 pages in length (double spaced), not including figures.
Abstract: 250 words maximum; unstructured
Manuscript Structure: Introduction, Methods, Results, Discussion, References          
Description: Must either be of current general interest or of great significance to a more specialized readership, and report unpublished studies

ii. Reviews
Page limit: Maximum of 50 double-spaced pages of text, includes text, footnotes, literature citations, tables, and legends, plus formulas, schemes, and figures if included
Abstract: 250 words maximum; unstructured
Description: Topics of current interest in all relevant areas of molecular recognition, can be literature or technical reviews. Generally invited but can be unsolicited

iii. Perspective
Page limit: Maximum of 3,000 words and 1 figure or table
Description: A perspective is a short peer-reviewed, free-format article that provides a viewpoint, opinion, commentary, or discussion on a topic relating to molecular recognition. They should present new insights or ideas, and be more personal and focused than a "Review" article. Topics include critical analysis of past research, discussion of key concepts, and opinions on future directions

iv. Letters to the Editor
Description: Short responses to published articles

Preparing the Submission

Free Format submission

Journal of Molecular Recognition now offers Free Format submission for a simplified and streamlined submission process. 

Before you submit, you will need:

• Your manuscript: this should be an editable file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract (which does need to be correctly styled), introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

• An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)

• Additional info, either within the manuscript or as separate title page, including:

o Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
o Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
     o data availability statement
     o funding statement
     o conflict of interest disclosure
     o ethics approval statement
     o patient consent statement
     o permission to reproduce material from other sources
     o clinical trial registration

To submit, login at the submission URL above and create a new submission. Follow the submission steps as required and submit the manuscript.

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.
If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a Latex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the Latex Main Document should be uploaded as a “LaTeX Supplementary File.”
Your main document file should include:
• A short informative title containing the major key words. The title should not contain abbreviations;
• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted; 
• Acknowledgments;
• Abstract structured (intro/methods/results/conclusion) or unstructured
• Up to ten keywords;
• Main body: introduction, materials & methods, results, discussion, conclusion
• References;
• Tables (each table complete with title and footnotes);
• Figures with legends.

The cover letter should state why the authors are submitting to the journal.

Supporting information should be supplied as separate files.

Authorship

Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.

Abstract

For all articles apart from Letters to the Editor, please provide an abstract of no more than 250 words containing the major keywords. This should be a concise summary of the whole paper, not just the conclusions, and should convey the importance of the work and be understandable without reference to the rest of the manuscript to a multidisciplinary audience. Abstracts should not contain any citation to other published works.

Keywords

Please provide a minimum of five, and maximum of ten, keywords.

Main Text

·  Oxford English Dictionary or American spelling is acceptable, provided usage is consistent within the manuscript.

·   Manuscripts that are written in English that is ambiguous or incomprehensible, in the opinion of the Editor, will be returned to the authors with a request to resubmit once the language issues have been improved.

·  Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Authors’ Contribution Statement

The individual contributions of each author must be specified in the Authors' contributions section. Please use authors' initials and state that all authors have read and approved the final manuscript. We look for something like this: S.W., N.J., D.W. and S.S. performed the research. S.W., N.J., H.H. and T.L. designed the research study. H.H. and S.S. contributed essential reagents or tools. S.W., N.J. and D.W. analysed the data. S.W. and N.J. wrote the paper.

References

All references should be numbered consecutively in order of appearance. In text citations should be superscript numbers in square brackets. All references must be complete and accurate. Where possible the DOI for the reference should be included at the end of the reference. Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Figures submitted in colour may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.

Additional Files

Graphical Table of Contents

The journal’s table of contents will be presented in graphical form with a brief abstract.

The table of contents entry must include the article title, the authors' names (with the corresponding author indicated by an asterisk), no more than 80 words or 3 sentences of text summarising the key findings presented in the paper and a figure that best represents the scope of the paper (see the section on abstract writing for more guidance).

The image supplied should fit within the dimensions of 50mm x 60mm, and be fully legible at this size.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following points provide general advice on formatting and style:

·  Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

·  Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units

·  · Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.

Editorial Policies and Ethical Considerations

Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on the confidentiality of the review process is available here.

Data Sharing and Data Accessibility

The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

·         US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.

·         UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).

·         European authors outside the UK should conform to Directive 2010/63/EU.

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognised research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:

·         Randomised trials: CONSORT

·         Observational studies: STROBE

·         Systematic reviews: PRISMA

·         Case reports: CARE

·         Qualitative research: SRQR

·         Diagnostic / prognostic studies: STARD

·         Quality improvement studies: SQUIRE

·         Economic evaluations: CHEERS

·         Animal pre-clinical studies: ARRIVE

·         Study protocols: SPIRIT

·         Clinical practice guidelines: AGREE

We also encourage authors to refer to and follow guidelines from:

·         Future of Research Communications and e-Scholarship (FORCE11)

·         National Research Council's Institute for Laboratory Animal Research guidelines

·         The Gold Standard Publication Checklist from Hooijmans and colleagues

·         Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI) website

·         FAIRsharing website

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.  

Nomenclature

Nomenclature, abbreviations and symbols should follow the latest rules of the International Union of Pure and Applied Chemistry (IUPAC). In IUPAC nomenclature, isotopic substitution is indicated by a prefix consisting of (1) any necessary locant numeral or numerals; (2) the atomic symbol with the mass number as a superscript to the left of the symbol; and (3) a subscript (other than the unity) indicating the number of such atoms. Trivial names should be avoided unless the compound is to be mentioned often in the text, in which case a systematic name should also be given the first time the trivial name is used.

Journal of Molecular Recognition also touches on biology and medicine, and therefore a wide range of nomenclature rules apply.

For biological and biochemical nomenclature authors should conform to the (identical) guidelines published in J Biol Chem 260:16-42 (1985) and Eur J Biochem 138:9-37 (1984)

For biomedical nomenclature authors should conform to rules given in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals prepared by the International Steering Committee of Medical Editors. Reprints of this document are available from the Editor, Annals of Internal Medicine.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

·         DNA Data Bank of Japan (DDBJ): www.ddbj.nig.ac.jp

·         EMBL Nucleotide Archive: ebi.ac.uk/ena

·         GenBank: www.ncbi.nlm.nih.gov/genbank

Proteins sequence data should be submitted to either of the following repositories:

·         Protein Information Resource (PIR): pir.georgetown.edu

Structural Data:

Structural data should be deposited in the relevant database (Protein Data Bank, BMRB, CCSD, etc.), including a validation report, database code/identifier provided for each structure reported, and these should accompany the submission in order for the paper to be considered for publication in the Journal of Molecular Recognition.

Computational Chemistry and Molecular Modeling

For manuscripts that include the results of computational chemistry or molecular modeling, the authors should include all the details that will enable other scientists to reproduce the results. Results obtained from methods that are neither described in the manuscript nor in previous published reports are not acceptable for publication. Computational details, including data such as force field parameters and equations defining the model, can be included in the paper itself or in the Supporting Information. Alternatively, references to the location of these data in the open literature can also be provided. Data needed to reproduce the calculations, e.g. input coordinate, topology and parameter files, as well as result files, e.g. coordinate files for docked structures, should be provided in Supporting Information or in a public repository.

Software used for calculations must be properly cited, including version number. References to the methods upon which the software is based must be provided. Software or scripts written by the authors to produce the results reported should be made available in the Supporting Information or in a public repository. A "Code availability" statement should be provided in all manuscripts for which software was used to generate the results.

Submissions, including the results of electronic structure calculations, should include the geometries of all the stationary points reported, which should be reported with their relative energies (as Cartesian coordinates in the manuscript or as Z matrices in the Supporting Information), along with their computed absolute energies (Hartree). When appropriate, the number of imaginary frequencies should be reported to enable identification of stable structures.

Data Deposition

This journal expects that data supporting the results in the paper will be archived in a community-trusted, subject-based, public repository. For examples of community-trusted repositories, consult the list in this section, and visit the Registry of Research Data Repositories or FAIRsharing to help identify registered and certified data repositories relevant to your subject area. Authors are required to provide a data availability statement to describe the availability or the absence of shared data (for more information and for a list of our template Data Availability Statements, please see Wiley´s Data Sharing Policy).

When data have been shared, authors are required to include in their Data Availability Statement a link to the repository they have used, and to cite in the reference section of their manuscript the data they have shared (see Section 3.5). Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. If sharing data compromises ethical standards or legal requirements then authors are not expected to share it. This can be indicated by choosing the appropriate Data Availability Statement from our template list, available under Wiley´s Data Sharing Policy.

If the repository allows a user to place the data under an embargo until publication or allows a user to place the release of the data on hold until publication, please ensure that the appropriate steps are taken to ensure that data release is coordinated with publication of the associated article.

If the repository allows reviewers to access the data during peer review, please provide details in the manuscript. Validation reports should be provided for peer-review purposes.

Please consider depositing your data in a subject-specific repository. If a subject-specific database is not available, please consider depositing your data in a generic or multidisciplinary repository, for example, Figshare, Zenodo, Dryad, RADAR, Open Science Framework, Science Data Bank, and Qresp.

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Authorship 

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;

2. Been involved in drafting the manuscript or revising it critically for important intellectual content;

3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and

4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

Author Licensing

If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: Authors who choose to publish Open Access will be charged a fee. A list of Article Publication Charges for Wiley journals is available here. 

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

Publication Process after Acceptance

Accepted Article Received in Production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.

Accepted Articles

The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online shortly after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, and are given a Digital Object Identifier (DOI), which allows them to be cited and tracked. After publication of the final version article (the article of record), the DOI remains valid and can still be used to cite and access the article.

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

Author Pronouns

Authors may now include their personal pronouns in the author bylines of their published articles and on Wiley Online Library. Authors will never be required to include their pronouns; it will always be optional for the author. Authors can include their pronouns in their manuscript upon submission and can add, edit, or remove their pronouns at any stage upon request. Submitting/corresponding authors should never add, edit, or remove a coauthor’s pronouns without that coauthor’s consent. Where post-publication changes to pronouns are required, these can be made without a correction notice to the paper, following Wiley’s Name Change Policy to protect the author’s privacy. Terms which fall outside of the scope of personal pronouns, e.g. proper or improper nouns, are currently not supported.

Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.

Citing this Article: eLocators

This journal now uses eLocators. eLocators are unique identifies for an article that service the same function page numbers have traditionally served in the print world. When citing this article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.

Post Publication

Access and Sharing

When the article is published online: 

·         The author receives an email alert (if requested).

·         The link to the published article can be shared through social media.

·         The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).

·        The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Promoting the Article

To find out how to best promote an article, click here.

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

Editorial Office Contact Details

[email protected]